108 related articles for article (PubMed ID: 25881749)
1. Molecular deregulation of signaling in lymphoid tumors.
Spina V; Martuscelli L; Rossi D
Eur J Haematol; 2015 Oct; 95(4):257-69. PubMed ID: 25881749
[TBL] [Abstract][Full Text] [Related]
2. Pathogenetic importance and therapeutic implications of NF-κB in lymphoid malignancies.
Lim KH; Yang Y; Staudt LM
Immunol Rev; 2012 Mar; 246(1):359-78. PubMed ID: 22435566
[TBL] [Abstract][Full Text] [Related]
3. Genetic aberrations of signaling pathways in lymphomagenesis: revelations from next generation sequencing studies.
Rossi D; Ciardullo C; Gaidano G
Semin Cancer Biol; 2013 Dec; 23(6):422-30. PubMed ID: 23665546
[TBL] [Abstract][Full Text] [Related]
4. Toll-like receptors signaling: A complex network for NF-κB activation in B-cell lymphoid malignancies.
Ntoufa S; Vilia MG; Stamatopoulos K; Ghia P; Muzio M
Semin Cancer Biol; 2016 Aug; 39():15-25. PubMed ID: 27402288
[TBL] [Abstract][Full Text] [Related]
5. Pathogenic B-cell receptor signaling in lymphoid malignancies: New insights to improve treatment.
Young RM; Phelan JD; Wilson WH; Staudt LM
Immunol Rev; 2019 Sep; 291(1):190-213. PubMed ID: 31402495
[TBL] [Abstract][Full Text] [Related]
6. NF-κB signaling pathway and its potential as a target for therapy in lymphoid neoplasms.
Yu L; Li L; Medeiros LJ; Young KH
Blood Rev; 2017 Mar; 31(2):77-92. PubMed ID: 27773462
[TBL] [Abstract][Full Text] [Related]
7. Unexpected features of acute T lymphoblastic lymphomas in Notch1IC transgenic rats.
van den Brandt J; Kwon SH; McPherson KG; Petrovic S; Zettl A; Müller-Hermelink HK; Reichardt HM
Eur J Immunol; 2006 Aug; 36(8):2223-34. PubMed ID: 16838279
[TBL] [Abstract][Full Text] [Related]
8. C-type lectin DC-SIGN modulates Toll-like receptor signaling via Raf-1 kinase-dependent acetylation of transcription factor NF-kappaB.
Gringhuis SI; den Dunnen J; Litjens M; van Het Hof B; van Kooyk Y; Geijtenbeek TB
Immunity; 2007 May; 26(5):605-16. PubMed ID: 17462920
[TBL] [Abstract][Full Text] [Related]
9. Multiple signaling pathways contribute to synergistic TLR ligand-dependent cytokine gene expression in human monocyte-derived macrophages and dendritic cells.
Mäkelä SM; Strengell M; Pietilä TE; Osterlund P; Julkunen I
J Leukoc Biol; 2009 Apr; 85(4):664-72. PubMed ID: 19164128
[TBL] [Abstract][Full Text] [Related]
10. The hepatitis B virus X protein downregulates NF-κB signaling pathways through decreasing the Notch signaling pathway in HBx-transformed L02 cells.
Luo J; Zhou H; Wang F; Xia X; Sun Q; Wang R; Cheng B
Int J Oncol; 2013 May; 42(5):1636-43. PubMed ID: 23450368
[TBL] [Abstract][Full Text] [Related]
11. Molecularly-targeted Strategy and NF-κB in lymphoid malignancies.
Horie R
J Clin Exp Hematop; 2013; 53(3):185-95. PubMed ID: 24369220
[TBL] [Abstract][Full Text] [Related]
12. Comprehending the complex connection between PKCbeta, TAK1, and IKK in BCR signaling.
Shinohara H; Kurosaki T
Immunol Rev; 2009 Nov; 232(1):300-18. PubMed ID: 19909372
[TBL] [Abstract][Full Text] [Related]
13. Toll-like receptor stimulation in cardiomyoctes decreases contractility and initiates an NF-kappaB dependent inflammatory response.
Boyd JH; Mathur S; Wang Y; Bateman RM; Walley KR
Cardiovasc Res; 2006 Dec; 72(3):384-93. PubMed ID: 17054926
[TBL] [Abstract][Full Text] [Related]
14. Nuclear factor-kappa β regulates Notch signaling in production of proinflammatory cytokines and nitric oxide in murine BV-2 microglial cells.
Cao Q; Kaur C; Wu CY; Lu J; Ling EA
Neuroscience; 2011 Sep; 192():140-54. PubMed ID: 21729740
[TBL] [Abstract][Full Text] [Related]
15. Regulation and function of NF-kappaB transcription factors in the immune system.
Vallabhapurapu S; Karin M
Annu Rev Immunol; 2009; 27():693-733. PubMed ID: 19302050
[TBL] [Abstract][Full Text] [Related]
16. Molecular Mechanisms of Notch Signaling in Lymphoid Cell Lineages Development: NF-κB and Beyond.
Tsaouli G; Barbarulo A; Vacca A; Screpanti I; Felli MP
Adv Exp Med Biol; 2020; 1227():145-164. PubMed ID: 32072504
[TBL] [Abstract][Full Text] [Related]
17. The two faces of myeloproliferative neoplasms: Molecular events underlying lymphoid transformation.
Holroyd A; Cross NC; Macdonald DH
Leuk Res; 2011 Oct; 35(10):1279-85. PubMed ID: 21722956
[TBL] [Abstract][Full Text] [Related]
18. Tetradecanoyl phorbol acetate induces expression of Toll-like receptor 2 in U937 cells: involvement of PKC, ERK, and NF-kappaB.
Jang BC; Jung TY; Paik JH; Kwon YK; Shin SW; Kim SP; Ha JS; Suh MH; Suh SI
Biochem Biophys Res Commun; 2005 Mar; 328(1):70-7. PubMed ID: 15670752
[TBL] [Abstract][Full Text] [Related]
19. B-cell receptor signaling in the pathogenesis of lymphoid malignancies.
Bojarczuk K; Bobrowicz M; Dwojak M; Miazek N; Zapala P; Bunes A; Siernicka M; Rozanska M; Winiarska M
Blood Cells Mol Dis; 2015 Oct; 55(3):255-65. PubMed ID: 26227856
[TBL] [Abstract][Full Text] [Related]
20. Activin suppresses LPS-induced Toll-like receptor, cytokine and inducible nitric oxide synthase expression in normal human melanocytes by inhibiting NF-κB and MAPK pathway activation.
Kim YI; Park SW; Kang IJ; Shin MK; Lee MH
Int J Mol Med; 2015 Oct; 36(4):1165-72. PubMed ID: 26259928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
